← United States · Coverage record
US · SEC FORM 4
Assertio Holdings, Inc.
ASRT · — · CIK 0001808665 · Healthcare
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
16 Form 4 transaction lines observed in the same window
0 sales · 16 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
Showing the six most active owners; 3 additional owner(s) remain in Form 4 evidence.
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2024-11-18 · Mason Heather L.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.
Price performance
- 1M
- —
- 3M
- —
- 6M
- —
- 12M
- —
Volatility & liquidity
- Volatility
- —
- Beta
- —
- Avg daily value
- —
Valuation
- Market cap
- —
- P/E
- —
Fundamentals
- Profit margin
- -25.6%
- ROE
- -32.3%
- Industry
- Pharmaceutical Preparations
Market data
Price data up to: 2026-10-08 · Price source: OpenBB/yfinance · From SEC filings: Profit margin, ROE · Fiscal year ended: 2025-12-31 · Status: PASS
Short interest
The FINRA report lists no short interest for this ticker.
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2024-11-18 | Mason Heather L | Purchase (P) | Common Stock | 75,000 | USD 0.80 | USD 60,000 | SEC filing ↗ |
| 2024-11-14 | O'Grady Brendan P. | Purchase (P) | Common Stock | 11,706 | USD 0.85 | USD 9,950 | SEC filing ↗ |
| 2024-06-11 | Vacirca Jeff L | Purchase (P) | Common Stock | 10,000 | USD 1.11 | USD 11,100 | SEC filing ↗ |
| 2024-06-05 | Mason Heather L | Purchase (P) | Common Stock | 25,000 | USD 0.97 | USD 24,250 | SEC filing ↗ |
| 2021-05-20 | Schwichtenberg Paul | Purchase (P) | Common Stock | 9,750 | USD 1.51 | USD 14,722 | SEC filing ↗ |
| 2021-05-20 | Peisert Daniel A. | Purchase (P) | Common Stock | 15,909 | USD 1.54 | USD 24,500 | SEC filing ↗ |
| 2021-05-20 | Patel Ajay | Purchase (P) | Common Stock | 8,170 | USD 1.53 | USD 12,500 | SEC filing ↗ |
Form 4 evidence
35 transaction lines in the latest 365-day window; 231 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-06-16 | Stark David Matthew | U (U) | Common Stock | 11,420 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-16 | Schwichtenberg Paul | U (U) | Common Stock | 13,987 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-16 | Schlessinger Sam | U (U) | Common Stock | 14,738 | USD 0.00 | USD 0 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-06-16 | Stark David Matthew | U (U) | Common Stock | 11,420 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-16 | Schwichtenberg Paul | U (U) | Common Stock | 13,987 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-16 | Schlessinger Sam | U (U) | Common Stock | 14,738 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-16 | Reisenauer Mark L | U (U) | Common Stock | 3,583 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-16 | Patel Ajay | U (U) | Common Stock | 15,942 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-16 | Mason Heather L | U (U) | Common Stock | 27,610 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-16 | MCKEE WILLIAM | U (U) | Common Stock | 27,936 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-16 | Kirk Sigurd | U (U) | Common Stock | 12,017 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-16 | Emany Sravan Kumar | U (U) | Common Stock | 23,855 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-13 | Mason Heather L | Gift (G) | Common Stock | 6,666 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-05 | Stark David Matthew | Award / grant (A) | Common Stock | 4,851 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-05 | Mason Heather L | Award / grant (A) | Common Stock | 4,851 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-05 | MCKEE WILLIAM | Award / grant (A) | Common Stock | 4,851 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-05 | Kirk Sigurd | Award / grant (A) | Common Stock | 4,851 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-05 | Emany Sravan Kumar | Award / grant (A) | Common Stock | 4,851 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-02-21 | Schwichtenberg Paul | Option exercise / conversion (M) | Common Stock | 1,143 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-02-21 | Schwichtenberg Paul | Tax withholding (F) | Common Stock | 566 | USD 11.84 | USD 6,701 | SEC filing ↗ |
| 2026-02-21 | Schlessinger Sam | Option exercise / conversion (M) | Common Stock | 1,143 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-02-21 | Schlessinger Sam | Tax withholding (F) | Common Stock | 510 | USD 11.84 | USD 6,038 | SEC filing ↗ |
| 2026-02-21 | Patel Ajay | Option exercise / conversion (M) | Common Stock | 1,143 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-02-21 | Patel Ajay | Tax withholding (F) | Common Stock | 566 | USD 11.84 | USD 6,701 | SEC filing ↗ |
| 2026-02-18 | Schwichtenberg Paul | Option exercise / conversion (M) | Common Stock | 2,778 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-02-18 | Schwichtenberg Paul | Tax withholding (F) | Common Stock | 1,377 | USD 11.87 | USD 16,345 | SEC filing ↗ |
| 2026-02-18 | Schlessinger Sam | Option exercise / conversion (M) | Common Stock | 2,778 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-02-18 | Schlessinger Sam | Tax withholding (F) | Common Stock | 1,239 | USD 11.87 | USD 14,707 | SEC filing ↗ |
| 2026-02-18 | Patel Ajay | Option exercise / conversion (M) | Common Stock | 2,778 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-02-18 | Patel Ajay | Tax withholding (F) | Common Stock | 1,377 | USD 11.87 | USD 16,345 | SEC filing ↗ |
| 2026-02-07 | Schwichtenberg Paul | Option exercise / conversion (M) | Common Stock | 1,666 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-02-07 | Schwichtenberg Paul | Tax withholding (F) | Common Stock | 825 | USD 12.74 | USD 10,510 | SEC filing ↗ |
| 2026-02-07 | Schlessinger Sam | Option exercise / conversion (M) | Common Stock | 1,389 | USD 0.00 | USD 0 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | ASRT |
| CIK | 0001808665 |
| Sector | Healthcare |
| Industry | — Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| Exchange | — |
Data coverage
| Local Form 4 history | 231 transaction lines from 2020-05-19 to 2026-06-16 7 P purchase lines · 19 S sale lines · 205 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.